There is no evidence to support the use of convalescent plasma to treat patients with COVID-19, and doctors should not consider it a standard of care until more research is completed, a panel of experts from the us National institutes of health said on Tuesday.
“There is not enough data to recommend for or against the use of convalescent plasma for the treatment of COVID-19,” a group of more than three dozen experts said in a statement posted on the NIH website, CNN reported.
“Convalescent plasma should not be considered the standard of care for patients with COVID-19,” said the Committee that evaluates treatments for the new coronavirus.
Convalescent plasma is the antibody-rich blood serum of people who have had an infection. The theory is that injecting this plasma to new patients with COVID-19 will boost their immune response, CNN reports.
Last week, the U.S. food and drug Administration issued a permit for emergency use of convalescent plasma to treat COVID-19.
“Prospective, well-controlled, sufficiently powerful randomized trials are required to determine whether plasma recovery is effective and safe for the treatment of COVID-19. The participation of members of the public and medical professionals in these prospective clinical trials is welcome,” the expert group said.